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ABSTRACT 30 
Purpose: To determine the effects of acute short-term creatine (Cr) supplementation on 31 
physical performance during a 90 minute soccer-specific performance test. Methods: A 32 
double-blind, placebo-controlled experimental design was adopted during which 16 33 
male amateur soccer players were required to consume 20 g of Cr per day, for seven 34 
days or a placebo.  A ball-sport endurance and speed test (BEAST) comprising 35 
measures of aerobic (circuit time), speed (12 and 20m sprint) and explosive power 36 
(vertical jump) abilities performed over 90 min was performed pre- and post-37 
supplementation.  Results: Performance measures during the BEAST deteriorated 38 
during the second half relative to the first for both Cr (1.2 to 2.3%) and placebo (1.0 to 39 
2.2%) groups, indicating a fatigue effect associated with the BEAST. However, no 40 
significant differences existed between groups suggesting that Cr had no performance 41 
enhancing effect or ability to offset fatigue. When effects sizes were considered, some 42 
measures (12m sprint: -0.53 ± 0.69; 20m sprint: -0.39 ± 0.59 showed a negative 43 
tendency, indicating chances of harm were greater than chances of benefit. 44 
Conclusions: Acute short-term Cr supplementation has no beneficial effect on physical 45 
measures obtained during a 90 minute soccer simulation test, thus questioning its 46 
potential as an effective ergogenic aid for soccer players. 47 
 48 
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INTRODUCTION 50 
Many athletes use nutritional ergogenic aids in an attempt to improve both the quality 51 
and quantity of training, and to enhance their performance during competition 1.  52 
Indeed, under specific conditions, many sporting ergogenic aids have been shown to 53 
have positive effects on athletic performance, body composition and strength 2 and it is 54 
possible that ingestion of additional nutrients may be necessary during high-intensity 55 
exercise to allow for maximal expression of endurance and strength gains 3.   56 
 57 
Athletes participating in team sports may benefit from the consumption of nutritional 58 
ergogenic aids. Many team sports are characterised by high energetic demands (e.g. 59 
repeated high-intensity efforts) over long durations (~70-90 min), sometimes with short 60 
recovery periods 4,5.  One such ergogenic aid that has gained popularity is creatine 61 
monohydrate (Cr).  Creatine is a naturally occurring compound derived from amino 62 
acids and is found primarily in skeletal muscle. Creatine exists in muscles as 63 
phosphocreatine (PCr), providing the high-energy phosphate for adenosine diphosphate 64 
(ADP) to restore adenosine triphosphate (ATP) concentration rapidly via the Cr kinase 65 
(CK) reaction 6.  Creatine can be ingested from natural exogenous sources, such as fish 66 
or red meat, ingested through supplementation, and produced endogenously by the body 67 
7. The average concentration of Cr in human muscle ([Cr]) is approximately 125 68 
mmol.kg-1 dry mass, but following 7 days of Cr supplementation it has been reported to 69 
increase total muscle [Cr] by 20 to 50% 8,9.   70 
 71 
Several studies to date have revealed beneficial effects of both chronic (>4 weeks) and 72 
acute (2 to 7 days) Cr supplementation on strength 10, power 8 and speed 11 in trained 73 
athletes. While most scientific support for the use of Cr to improve performance is 74 
associated with sports or single bout events requiring high anaerobic power7, there is 75 
need for intermittent team sports athletes to repeatedly produce high-intensity explosive 76 
bouts typically over prolonged game durations (60-90 minutes). It is also possible that 77 
the ability to metabolically recover during high-intensity intermittent activity may be 78 
enhanced using oral Cr, given its role as a metabolic buffer 12, ability to reduce ATP 79 
loss during maximal exercise 13 and improve PCr resynthesis 14.  80 
 81 
While it seems reasonable to suggest that team sport players could benefit from such Cr 82 
supplementation, with studies having reported positive effects of Cr on discrete physical 83 
performance tasks (e.g sprinting, jumping) relevant to team sport athletes 15-18. 84 
However, few studies have reported the effects of acute Cr supplementation on actual or 85 
simulated soccer performance 19 over a full 90 minute (2 x 45 min) period.  It is 86 
extremely difficult to quantify the effects of any type of intervention on actual soccer 87 
match play due to the high match-to-match variations in physical performance caused 88 
by factors such as changing opposition, the weather, the score, and position in 89 
league/competition. Likewise, the effects of a nutritional ergogenic aid on soccer 90 
performance cannot be validly assessed by simply quantifying physical performance 91 
effects measured in isolation from the true physical demands of prolonged intermittent 92 
activity. In an attempt to address this, Cox et al. 19 investigated the effects of acute Cr 93 
ingestion in female soccer players during a 5 x 12 min soccer simulation protocol with a 94 
total duration of 60 min and reported significantly faster sprint times in 9 of the 55 95 
sprints. However, the mean sprint time for the Cr group was not significantly faster 96 
post-supplementation. Moreover, a consistent finding in studies of Cr supplementation 97 
is a significant increase in body mass of around 1.5 kg 20. Conceivably, this increase in 98 
body mass in a weight-supported sport like soccer could decrease performance by 99 
increasing the energy cost of running. Given that muscle glycogen stores have been 100 
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reported to be almost empty after a soccer match21, then increasing the energy cost of 101 
running via an increased body mass would only exacerbate this problem. 102 
 103 
Clearly there is a need for more research assessing the effects of acute short-term Cr 104 
supplementation using appropriate protocols that simulate the actual intensity demands 105 
and duration of a full game. Therefore, the aim of this study was to determine the acute 106 
effects of Cr supplementation on physical performance during a 90 minute soccer-107 
specific simulation. 108 
 109 
Methods 110 
Experimental Design 111 
A double-blind, placebo-controlled independent-groups design was adopted.  Using a 112 
matched-pairs design, based on pre-intervention Yo-Yo Intermittent Recovery Test 113 
(YYIRT) scores, subjects were assigned to either an experimental group (Cr), or a 114 
placebo group. Before and after supplementation players were required to attend testing 115 
sessions involving familiarisation and two full trials of the Ball-sport Endurance And 116 
Sprint Test (BEAST) and YYIRT.   117 
 118 
Subjects 119 
With institutional ethics approval, 16 healthy male soccer players from an amateur 120 
soccer league volunteered to participate in the study.  The descriptive characteristics of 121 
participants are presented in Table 1. Participants were pre-screened via medical 122 
questionnaire for any previous or current injuries and medical conditions that would 123 
contraindicate participation.  In addition, participants were required to attest to having 124 
not consumed any sporting ergogenic aid(s) over the three month period prior to the 125 
study and agreed to provide dietary records two days prior to test sessions for later 126 
replication.  Each subject provided written informed consent before any testing 127 
commenced.   128 
129 
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**Insert Table 1 about here** 130 
 131 
Test Protocols 132 
All tests were conducted indoors in a well-ventilated, temperature controlled (~19oC, 133 
50-60%rH) sports facility. 134 
 135 
Yo-Yo Intermittent Recovery Test 136 
The YYIRT has been shown to be a reliable and valid test for assessing soccer-specific 137 
fitness 22.  The YYIRT consists of incremental shuttle running until exhaustion, with 138 
pace determined by an audible signal.  Every second 20 m shuttle, players have ten 139 
seconds of active recovery consisting of 2 x 2.5 m walking.  The test is terminated when 140 
the player fails to reach the line over two consecutive times (objective evaluation by two 141 
research assistants) or the player withdraws because of volitional exhaustion (subjective 142 
evaluation).  The test score is the total distance (meters) covered during the test.   143 
 144 
Soccer Simulation protocol 145 
The BEAST protocol was designed from previous soccer match analysis studies 23-26 146 
and has been reported to be valid and reliable 27. The BEAST protocol consists of two 147 
laps that make up one circuit (Figure 1).  Each circuit (380.4 m) is repeated 148 
continuously for 45 minutes (first half), followed by a half-time recovery period of ten 149 
minutes; then repeated for a further 45 minutes (second half). Sprinting, backwards 150 
jogging, walking, jogging / decelerating, and forwards running make up 8.4%, 8.4%, 151 
9.7%, 24.5% and 39% of the total distance covered per circuit. During the BEAST, HR 152 
was measured continuously using a Polar Team HR system (Polar Electro, Oy, 153 
Kempele, Finland). Body-mass was measured and recorded to the nearest 0.1 kg pre-154 
trial, at half-time and upon completion of the BEAST. Dual electronic timing lights 155 
(Speed-Light, Swift Performance, Melbourne, Australia) were used to record 12 m and 156 
20 m sprint times during the entire BEAST protocol, as well as circuit time.  A jump 157 
Mat (Swift Performance Melbourne, Australia) was used to measure vertical jump (VJ) 158 
height during each circuit of the BEAST. During the BEAST, participants were not 159 
permitted to drink, but water was provided during the half-time period. Ingested fluid 160 
volume was recorded and repeated for subsequent trials. 161 
 162 
**Insert Figure 1 about here** 163 
 164 
Supplementation 165 
Subjects were supplemented with either Cr or a placebo (Cornflour, Edmonds, 166 
Auckland, NZ) for seven days following the initial pre-testing.  All subjects received 167 
plastic vials each filled with 20 g of commercially available, 100% pharmaceutical 168 
grade, Cr monohydrate powder (Horleys, Auckland, New Zealand), which was mixed in 169 
with 8 g of flavored glucose powder to disguise the taste.  The placebo group received 170 
plastic vials each filled with 20 g of cornflour, also mixed with 8 g of flavoured glucose 171 
powder making it indistinguishable from Cr in terms of flavour, texture and appearance.  172 
Subjects were verbally reminded each day to consume their prescribed supplement four 173 
times per day, with ~4 hours between dosages.   174 
 175 
Creatine in Urine 176 
Previous work has found that once Cr stores are filled after Cr supplementation, un-177 
wanted Cr is excreted into the urine 28.  Participants were required to provide a 50 ml 178 
mid-catch, early morning, urine sample on days 1 (pre-supplementation) and 8 (post-179 
supplementation) of the study. All samples were frozen at -40oC until batch analysis. 180 
  6  
Urinary Cr concentrations were determined before and after the dosing period in 181 
duplicate using an enzymatic colorimetric PAP test (Roche Diagnostics GmbH, 182 
Mannheim, Germany).   183 
 184 
Statistical Analysis 185 
Data were analysed using SPSS (Version 14.0) and specially created analysis 186 
spreadsheets for determination of confidence limits and qualitative interpretations of 187 
benefit and harm 29. The effects of Cr supplementation were analysed by repeated 188 
measures ANOVA, with differences considered statistically significant when P<0.05.  189 
Most models included Group (Cr and placebo) as a between-subjects factor, Trial (pre 190 
and post) as a within-subjects factor and Interval (generally either two x 45 minutes or 191 
six x 15 minutes) as a second within-subjects factor.  Bonferroni procedures were 192 
employed for post-hoc comparisons to reduce the probability of Type I errors.  Cohen’s 193 
d statistic was employed as the measure of effect size (ES) and defined as small (0.20), 194 
medium (0.50) and large (0.80).  Hopkins’ 29 spreadsheet was used to determine the ES 195 
and 90% confidence limits and the chances that the true effect was substantial.  196 
 197 
Results 198 
There were no significant differences between groups for any measure prior to Cr 199 
supplementation (Table 1). All subjects tolerated the Cr supplementation protocol with 200 
no reports of gastrointestinal distress, muscular cramping or other symptoms.  Reported 201 
compliance of Cr ingestion was 100%. There was no evidence of weight gain after Cr 202 
supplementation (Cr: Pre, 79.8 ± 8.6 vs. Post, 79.7 ±10.4 kg; PLAC: Pre 80.8 ±10.5 vs. 203 
Post, 81.0 ±8.5 kg). The urinary Cr, determined pre- and post-Cr supplementation for 204 
both groups, is presented in Figure 2. 205 
 206 
**Insert Figure 2 about here** 207 
 208 
Pre- and post-supplement YYIRT and BEAST performance measures, per half and 209 
averaged over the full 90 minute protocol, are shown in Table 2. There were no 210 
significant main effects for Group or Trial, nor significant interaction effects 211 
(Group*Trial, Group*Interval, Trial*Interval, Group*Trial*Interval) for mean circuit 212 
time, 12 or 20 m sprint time or VJ height. Effect sizes of Cr (relative to placebo) over 213 
the full 90 minute BEAST protocol, and the chances that the true effect was substantial, 214 
are shown in Table 3.   215 
 216 
**Insert Table 2 about here** 217 
**Insert Table 3 about here** 218 
 219 
Within trial comparisons, at 15 min intervals, are presented in Figures 3a-d for both 220 
PLAC and Cr.  221 
 222 
**Insert Figure 3a-d about here** 223 
 224 
DISCUSSION 225 
 226 
Despite widespread use of Cr by athletes and numerous research studies and reviews  227 
investigating and evaluating its effect on performance 30, this study, to our knowledge, 228 
is the first to report the effects of Cr on physical performance during trials that closely 229 
replicate the true demands and duration of soccer match play.  230 
 231 
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Soccer is largely an aerobic sport 31 and well-developed aerobic fitness and the ability to 232 
repeatedly perform and recover from high-intensity exercise bouts 5 are essential to 233 
compete at the highest level. The lack of effect of Cr on mean circuit time during the 234 
BEAST in the present study is consistent with other studies which have investigated the 235 
effects of both short and long-term Cr ingestion on isolated measures of aerobic 236 
performance 32-35. The lack of change in aerobic performance after acute short-term Cr 237 
supplementation seems logical from a physiological perspective, since the aerobic 238 
energy system is not dependent on PCr as an immediate energy source. However, we 239 
acknowledge that improved mean circuit time could be achieved by other Cr induced 240 
improvements in physical ability such as increased agility, jumping, sprinting ability 36 241 
and recovery from such activities, caused by enhanced PCr and ATP resynthesis rates 14 242 
and decreased muscle relaxation time 37.  Accordingly, we anticipated an increase in 243 
YYIRT performance after Cr supplementation, given that this test involves high 244 
intensity intermittent activity with limited recovery.  Physiologically, it could be 245 
assumed that subjects in the Cr group would have an accelerated PCr recovery in 246 
between shuttles, due to the more freely available Cr for PCr resynthesis. Consistent 247 
with our findings for mean circuit time, enhanced YYIRT performance was not 248 
observed.  249 
 250 
The progressive fatigue that occurs in soccer 38 has been attributed to several factors 251 
including the depletion of muscle glycogen, reductions in circulating blood glucose, 252 
hyperthermia, and dehydration 39.  It is plausible that the degree of fatigue observed 253 
during the BEAST (1.5 to 2.5% drop from 1st half to second half, Table 2) could be due 254 
to these mechanisms, and potentially from a depletion of PCr and decreased pH which 255 
have both been associated with the state of fatigue in skeletal muscle and the decline in 256 
muscle power during high-intensity exercise 40.  However, following Cr 257 
supplementation, there were no significant Group*Trial or Group*Trial*Interval 258 
interactions for any of the four BEAST performance measures (mean circuit time, 12 m 259 
sprint, 20 m sprint and VJ), body-mass or HR values, suggesting that Cr had no physical 260 
performance enhancing effect during the 90 minute BEAST protocol.   261 
 262 
Although most previous soccer-related Cr studies have not used soccer-specific (jumps, 263 
turns, walking, running, sprinting etc) protocols of sufficient duration (90 mins), the 264 
results of the present study are in agreement with previous Cr studies that have utilised 265 
isolated physical tasks involving soccer players 18 or other team sport athletes 8,36,41,42.  266 
However, the present results oppose the reported enhancement in sprint performance 267 
seen in other soccer-related 15-17,32 and team sport studies 8,32. The study by Cox et al 19, 268 
involving 14 elite female soccer players, is most relevant as it investigated the effects of 269 
six days of Cr supplementation (20 g.day-1) during 5 x 12 minute exercise bouts 270 
involving 20 m sprints, agility, and a ball kicking drill, separated by recovery walks, 271 
jogs and runs. In contrast to our findings, the Cr group achieved consistently faster post-272 
supplementation times between sprints 10 and 47, reaching statistical significance for 273 
nine (out of 55; 16%) 20 m sprints, although there was no significant improvement in 274 
the mean sprint time. Agility was also improved (2.2%). The conflicting outcomes of 275 
the present study and that of Cox et al 19 could be due to differences in gender and 276 
playing level of the subjects, the shorter duration of the adopted protocol and, though 277 
not reported by Cox et al 19, differences in subjects’ Cr stores compared to the present 278 
study. This would explain the reported improvements in sprint times as well as 279 
increased body-mass after Cr supplementation in the Cox et al 19 study but not ours.   280 
 281 
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As previously discussed there is usually an increase in body mass of around 1.5 kg 282 
following acute Cr supplementation. Although in the present study there was no 283 
significant change in body mass in the Cr group following supplementation, we did 284 
observe a large increase in urinary Cr post-supplementation (Figure 2). The mean post-285 
supplementation urinary Cr concentration was greater than 10 times the resting 286 
concentration of the placebo group, suggesting that those in the Cr group had 287 
sufficiently increased total muscle [Cr] to a level where the majority of ingested Cr was 288 
being excreted in the urine. Although an increase in body mass following Cr 289 
supplementation is usual, it does not always occur. Studies by Zuniga et al43 and 290 
Reardon et al.44 both failed to observe an increase in body mass following Cr 291 
supplementation. The reasons for why body mass did not increase following Cr 292 
supplementation in the current study are unknown, but based on the urinary Cr data 293 
those in the Cr group should have substantially increased their [Cr] after 294 
supplementation. However, we also acknowledge that given the absence of muscle [Cr] 295 
measures in the present study, it is possible that both groups in our study already had 296 
elevated muscle Cr stores at baseline and that Cr supplementation had little impact on 297 
increasing muscle [Cr]. This could also explain the lack of change in body mass and 298 
performance measures following supplementation. 299 
 300 
In the present study, explosive leg power, as measured by the VJ test during the BEAST 301 
protocol, was not enhanced by acute Cr supplementation. These findings are in 302 
agreement with Miszko et al 42 and Mujika et al 16, who found no change in VJ or 303 
counter movement jumps (CMJ) respectively, after acute short-term Cr ingestion.  In 304 
contrast, Ostojic 17 reported a 10.8% increase in VJ performance after 7 days of Cr 305 
supplementation in young soccer players. Similarly, Izquierdo et al 32 also reported CMJ 306 
values to increase (5.1%) after acute short-term Cr supplementation.   307 
 308 
When assessed for the whole 90 minute BEAST protocol, all effects of Cr were 309 
negative and correspondingly, the chances of a detrimental effect were greater than the 310 
chances of a beneficial effect. This is important as it illustrates the potentially greater 311 
chance for Cr to be harmful than to be beneficial to performance which opposes 312 
previous findings of a neutral effect of Cr on aerobic performance 45.  For 12 and 20 m 313 
sprint time, the chances of Cr having a beneficial effect were considered very unlikely 314 
(1 to 5%). The disparity between likelihoods of benefit versus harm for mean circuit 315 
time and vertical jump were insufficient for a clear assessment to be made, however, the 316 
likelihoods of a detrimental effect were 8.7 and 4.1 times greater for circuit time and 317 
vertical jump respectively. 318 
 319 
Practical Applications 320 
From an applied perspective, the lack of effect of Cr supplementation on physical 321 
performance tests that closely simulate the intensity and duration of soccer indicates that 322 
its use as an ergogenic aid in prolonged intermittent team sports is questionable. 323 
 324 
Conclusion 325 
In summary, the findings of the present study suggest that short-term Cr 326 
supplementation does not enhance repeated high-intensity or prolonged soccer-specific 327 
exercise performance. Furthermore, the tendency of magnitude-based practical 328 
inferences to reveal greater chances of harm than benefit would indicate that 329 
consumption of Cr is not a worthwhile strategy for soccer players. 330 
 331 
 332 
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Figure Legends 455 
 456 
Figure 1. Schematic representation of the Ball-Sport Endurance and Speed Test 457 
(BEAST). 458 
 459 
Figure 2. Urinary creatine pre- and post-supplementation 460 
 461 
Figure 3a-d. Mean (±SD) 15-minute interval performance for a) mean circuit time; b) 462 
20 m sprint time; c) 12 m sprint time and d) vertical jump height during the BEAST 463 
protocol, pre- and post-supplementation, for both the Cr (●) and PLAC (○) groups. * 464 
represents significant difference between the first 15 min interval and subsequent 465 
intervals. 466 
 467 
 468 
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Table 1. Participant descriptive characteristics. Values are mean ± SD 
 
Group 
 
 
Age  
(years) 
 
 
Height  
(cm) 
 
 
Body-mass  
(kg) 
 
Playing 
Experience 
(years) 
YYIRT 
(m) 
Creatine (n=8) 25.4 ± 4.5 179.3 ± 4.6 79.3 ± 10.5 18.7 ± 5.4 1068 ± 473 
Placebo (n=8) 26.7 ± 4.6 178.9 ± 5.1 80.8 ± 8.6  19.4 ± 4.3 1065 ± 387 
Table 2. Pre- and post-supplement physical performance variables during the BEAST. 
Values are mean ± SD. 
 Creatine Group  
(n = 8) 
Placebo Group 
 (n = 8) 
 Pre Post Pre Post 
Mean circuit time (s)     
1st Half 190 ± 13 189 ± 10 196 ± 11 193 ± 15 
2nd Half 193 ± 13* 192 ± 8* 199 ± 14* 195 ± 17* 
Total 193 ± 12 191 ± 8 198 ± 13 194 ± 19 
Mean 12 m sprint time (s)     
1st Half 2.13 ± 0.14 2.13 ± 0.13 2.18 ± 0.08 2.13 ± 0.09 
2nd Half 2.18 ± 0.19* 2.18 ± 0.16* 2.22 ± 0.11* 2.16 ± 0.11* 
Total 2.16 ± 0.14 2.16 ± 0.04 2.20 ± 0.09 2.15 ± 0.08 
Mean 20 m sprint time (s)     
1st Half 3.24 ± 0.22 3.28 ± 0.21 3.28 ± 0.14 3.21 ± 0.15 
2nd Half 3.32 ± 0.18* 3.32 ± 0.22* 3.33 ± 0.17* 3.25 ± 0.20* 
Total 3.30 ± 0.20 3.30 ± 0.04 3.30 ± 0.15 3.23 ± 0.19 
Mean vertical jump height (cm)     
1st Half 38.8 ± 8.7 38.3 ± 8.8 33.1 ± 4.7 31.5 ± 7.1 
2nd Half 37.7 ± 7.9 37.2 ± 9.1 31.6 ± 4.8* 30.8 ± 7.8 
Total 38.3 ± 1.0 37.7 ± 1.2 32.4 ± 4.7 31.1 ± 7.7 
Heart rate (b.min-1)      
1st Half 166 ± 13 165 ± 14 168 ±  8 166 ± 12 
2nd Half 160 ± 11* 159 ± 13* 167 ± 9 164 ± 10 
Total 164 ± 11 162 ± 14 164 ± 8 166 ± 10 
RPE (AU)     
1st Half 12.4 ± 1.5 12.2 ± 1.1 12.9 ± 1.7 12.6 ± 1.4 
2nd Half 14.0 ± 2.3* 13.8 ± 2.4* 14.7 ±  1.7* 13.1 ± 1.9 
Total 13.2 ± 2.1 13.1 ± 2.0 14.2 ± 1.4 12.9 ± 1.8 
Where * = Significant difference between 1st and 2nd halves, P<0.05. 
 
Table 3. Effect of creatine (relative to placebo) on physical performance measures during the 
90 minute BEAST and YYIRT. 
  Chances that the true effect was substantial2 
Performance  Benefit Harm Practical 
Measure Cohen ES1 % % Assessment3 
Circuit Time -0.22 ± 0.54 6 52 Unclear 
12 m Sprint -0.53 ± 0.69 2 84 Benefit very unlikely/harm possible 
20 m Sprint -0.39 ± 0.59 3 75 Benefit very unlikely/harm possible 
VJ -0.13 ± 0.48 9 37 Unclear 
YYIRT -0.12 ± 0.63 14 40 Unclear 
1 ES values are shown as positive where the effect of Cr is beneficial and negative where the effect is 
detrimental. Values are ES ± 90% confidence interval. 
2 Cohen ES ≥ 0.2 29 
3 If chance of benefit or harm were both >5%, true effect was assessed as unclear (could be beneficial or 
harmful).  Otherwise, chances of benefit or harm were assessed as: <1%, almost certainly not; 1-5%, very 
unlikely; 5-25%, unlikely; 25-75%, possible; 75-95%, likely; 95-99%, very likely; >99%, almost certain. 
 
